Vasoprotection by nitric oxide: mechanisms and therapeutic potential

Area of Science:

• Vascular Biology
• Endothelial Function
• Nitric Oxide Signaling

Background:

• Endothelial nitric oxide (NO) plays a crucial role in maintaining vascular health through vasodilation, anticoagulation, and anti-inflammatory effects.
• Impaired NO bioavailability, often caused by increased reactive oxygen species (ROS), is implicated in various cardiovascular diseases including atherosclerosis, hypertension, and diabetes.
• Understanding the mechanisms of NO's vasoprotective actions is vital for developing therapeutic strategies.

Purpose of the Study:

• To review the cellular and molecular mechanisms of NO's vasoprotective effects.
• To discuss pharmacological approaches targeting the NO pathway for improving endothelial function and mitigating atherosclerotic vascular disease progression.

Main Methods:

• Literature review of cellular and molecular mechanisms of NO.
• Analysis of the role of NO in various disease states.
• Examination of pharmacological interventions targeting the NO pathway.

Main Results:

• NO exerts vasoprotective effects through both cyclic guanosine monophosphate (cGMP)-dependent and independent pathways.
• Impaired NO activity is a common feature in conditions like atherosclerosis, hypertension, diabetes, and hypercholesterolemia.
• Established drugs like ACE inhibitors and statins may exert beneficial effects partly through enhancing NO pathways.

Conclusions:

• There is strong evidence for NO's vasoprotective actions mediated by cGMP-dependent and independent mechanisms.
• Pharmacological targeting of the NO pathway holds promise for treating endothelial dysfunction and atherosclerotic vascular disease.
• Future therapeutic options may include L-arginine supplementation or novel NO pathway activators, though long-term nitrate data is limited.